Hyaluronan microspheres for sustained gene delivery and site-specific targeting.

Hyaluronan is a naturally occurring polymer that has enjoyed wide successes in biomedical and cosmetic applications as coatings, matrices, and hydrogels. For controlled delivery applications, formulating native hyaluronan into microspheres could be advantageous but has been difficult to process unless organic solvents are used or hyaluronan has been modified by etherification. Therefore, we present a novel method of preparing hyaluronan microspheres using adipic dihydrazide mediated crosslinking chemistry. To evaluate their potential for medical applications, hyaluronan microspheres are incorporated with DNA for gene delivery or conjugated with an antigen for cell-specific targeting. The results show that our method, originally developed for preparing hyaluronan hydrogels, generates robust microspheres with a size distribution of 5-20mum. The release of the encapsulated plasmid DNA can be sustained for months and is capable of transfection in vitro and in vivo. Hyaluronan microspheres, conjugated with monoclonal antibodies to E- and P-selectin, demonstrate selective binding to cells expressing these receptors. In conclusion, we have developed a novel microsphere preparation using native hyaluronan that delivers DNA at a controlled rate and adaptable for site-specific targeting.

[1]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[2]  D. Messadi,et al.  Binding and internalization of hyaluronate by human cutaneous fibroblasts. , 1992, Matrix.

[3]  G. Molema,et al.  Selective Intracellular Delivery of Dexamethasone into Activated Endothelial Cells Using an E-Selectin-Directed Immunoconjugate , 2002, The Journal of Immunology.

[4]  K. Goa,et al.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. , 1994, Drugs.

[5]  G. Prestwich,et al.  Novel Hydrogels of Hyaluronic Acid: Synthesis, Surface Morphology, and Solid-State NMR , 1994 .

[6]  G S Kansas,et al.  Selectins and their ligands: current concepts and controversies. , 1996, Blood.

[7]  Robert Langer,et al.  Biodegradable Polymer Scaffolds for Tissue Engineering , 1994, Bio/Technology.

[8]  S. Badylak Modification of Natural Polymers , 2002 .

[9]  E. Turley,et al.  Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action , 1998, FEBS letters.

[10]  G. Prestwich,et al.  Functionalized derivatives of hyaluronic acid oligosaccharides: drug carriers and novel biomaterials. , 1994, Bioconjugate chemistry.

[11]  L. Juhlin Hyaluronan in skin , 1997, Journal of internal medicine.

[12]  W. Godwin Article in Press , 2000 .

[13]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[14]  B. Toole,et al.  Hyaluronan in morphogenesis , 1997, Seminars in cell & developmental biology.

[15]  R. Cotran,et al.  Identification of an inducible endothelial-leukocyte adhesion molecule. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Allport,et al.  CD11b/CD18‐coated microspheres attach to E‐selectin under flow , 2000, Journal of leukocyte biology.

[17]  D. Nance,et al.  Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility [published erratum appears in J Cell Biol 1992 Aug;118(3):753] , 1992, The Journal of cell biology.

[18]  J. Scott,et al.  Extracellular matrix, supramolecular organisation and shape. , 1995, Journal of anatomy.

[19]  Peter Carmeliet,et al.  Growing better blood vessels , 2001, Nature Biotechnology.

[20]  B. Furie,et al.  Expression cloning of a functional glycoprotein ligand for P-selectin , 1993, Cell.

[21]  N A Peppas,et al.  New challenges in biomaterials. , 1994, Science.

[22]  L. Cipelletti,et al.  Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. , 2002, Blood.

[23]  E. Balazs,et al.  The chemistry, biology and medical applications of hyaluronan and its derivatives , 1998 .

[24]  U. Rothe,et al.  Selectins as new targets for immunoliposome-mediated drug delivery. A potential way of anti-inflammatory therapy. , 1998, Pharmaceutica acta Helvetiae.

[25]  E. Topp,et al.  Microspheres of hyaluronic acid esters—Fabrication methods and in vitro hydrocortisone release , 1990 .

[26]  G. Farrar,et al.  Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[27]  G. Prestwich,et al.  Chemical Modification of Hyaluronic Acid for Drug Delivery, Biomaterials and Biochemical Probes , 1998 .

[28]  P. B. Deasy,et al.  Microencapsulation and related drug processes , 1984 .

[29]  J. Clegg,et al.  Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. , 1997, Vaccine.

[30]  E. Balazs,et al.  Clinical uses of hyaluronan. , 2007, Ciba Foundation symposium.

[31]  Douglas J. Goetz,et al.  Ligand Coated Nanosphere Adhesion to E- and P-Selectin under Static and Flow Conditions , 2001, Annals of Biomedical Engineering.

[32]  David D Spragg,et al.  Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  L. McIntire,et al.  Cell Adhesion Under Hydrodynamic Flow Conditions , 1995, Current protocols in immunology.

[34]  K. Paigen,et al.  A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.

[35]  D J Berry,et al.  Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[36]  E. Coligan Current protocols in immunology , 1991 .

[37]  B. Ponder,et al.  Organ-related differences in binding of Dolichos biflorus agglutinin to vascular endothelium. , 1983, Developmental biology.

[38]  D. Jones,et al.  Antigenic heterogeneity of renal endothelium , 1989, The Journal of pathology.

[39]  D. Crommelin,et al.  Adhesion molecules: a new target for immunoliposome‐mediated drug delivery , 1995, FEBS letters.

[40]  J M Davidson,et al.  Hyaluronate derivatives and their application to wound healing: preliminary observations. , 1991, Clinical materials.

[41]  K. Comess,et al.  Isolated P-selectin Glycoprotein Ligand-1 Dynamic Adhesion to P- and E-selectin , 1997, The Journal of cell biology.

[42]  G. Kwon,et al.  Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[43]  A. Harris,et al.  The increased expression of adhesion molecules ICAM‐3, E‐ and P‐selectins on breast cancer endothelium , 1995, The Journal of pathology.

[44]  B. Gerdin,et al.  Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation , 1997, Journal of internal medicine.

[45]  Anthony Atala,et al.  Methods Of Tissue Engineering , 2006 .

[46]  J. Dickerson,et al.  Limited adhesion of biodegradable microspheres to E- and P-selectin under flow. , 2001, Biotechnology and bioengineering.

[47]  Y. Hsu,et al.  Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres. , 1999, Journal of drug targeting.

[48]  E. Berg,et al.  Humanization and pharmacokinetics of a monoclonal antibody with specificity for both E- and P-selectin. , 1998, Journal of immunology.

[49]  F. Luscinskas,et al.  Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. , 1996, Annual review of medicine.

[50]  R. Langer,et al.  Biomaterials in drug delivery and tissue engineering: one laboratory's experience. , 2000, Accounts of chemical research.

[51]  B. Toole Hyaluronan and its binding proteins, the hyaladherins. , 1990, Current opinion in cell biology.

[52]  Weiliam Chen,et al.  Characterization of DNA-hyaluronan matrix for sustained gene transfer. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[53]  S. Slack,et al.  Particle diameter influences adhesion under flow. , 2001, Biophysical journal.

[54]  T. Laurent,et al.  Catabolism of hyaluronan , 1998 .

[55]  K. March,et al.  Gene therapy for restenosis: getting nearer the heart of the matter. , 1998, Circulation research.